Used in the treatment of moderate to severe atopic dermatitis, particularly in patients who do not respond well to topical therapies. It targets and neutralizes interleukin-13 (IL-13), a key cytokine involved in the inflammatory response associated with allergic skin conditions. By blocking IL-13, it helps reduce skin inflammation, itching, and lesions. Also investigated for use in other IL-13-mediated diseases such as asthma and eosinophilic esophagitis. Administered via subcutaneous injection, it offers a targeted biologic therapy option with a favorable safety profile in chronic management.